Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) EBT Margin (2016 - 2025)

Nephros has reported EBT Margin over the past 16 years, most recently at 1.31% for Q4 2025.

  • Quarterly results put EBT Margin at 1.31% for Q4 2025, down 809.0% from a year ago — trailing twelve months through Dec 2025 was 6.53% (up 595.0% YoY), and the annual figure for FY2025 was 6.42%, up 579.0%.
  • EBT Margin for Q4 2025 was 1.31% at Nephros, down from 7.14% in the prior quarter.
  • Over the last five years, EBT Margin for NEPH hit a ceiling of 11.87% in Q1 2025 and a floor of 71.98% in Q1 2022.
  • Median EBT Margin over the past 5 years was 10.4% (2023), compared with a mean of 17.19%.
  • Biggest five-year swings in EBT Margin: crashed -3440bps in 2022 and later soared 6400bps in 2023.
  • Nephros' EBT Margin stood at 26.76% in 2021, then fell by -1bps to 26.94% in 2022, then grew by 29bps to 19.11% in 2023, then surged by 149bps to 9.41% in 2024, then plummeted by -86bps to 1.31% in 2025.
  • The last three reported values for EBT Margin were 1.31% (Q4 2025), 7.14% (Q3 2025), and 5.57% (Q2 2025) per Business Quant data.